Investment Powers the Debut of Pyxa: A Groundbreaking Platform for 3D Spatial Biology Research BOSTON — Stellaromics, a pioneer in 3D spatial biology spun out of the laboratories of Karl Deisseroth (Stanford University) and Xiao Wang (MIT and Broad Institute), today announced the completion of a Series B funding round in the amount of $80M. […]
Shimadzu Corporation has invested in Basetwo Artificial Intelligence, Inc. (Basetwo), through its Corporate Venture Capital (CVC) fund, “Shimadzu Future Innovation Fund” (Shimadzu FIF). Basetwo is developing process informatics (PI) ※1 tools that optimize manufacturing conditions and predict failures through simulation of pharmaceutical and chemical manufacturing processes. Traditional production management systems face challenges in addressing productivity declines and […]
Paris, Riom, Delray Beach, Florida – VERDOT, supported by its majority shareholders, Qualium Investissement and Lauxera Capital Partners, is pleased to announce a €10 million investment from BioProcess360, a specialized, US-based investment fund focused on the bioprocessing and life sciences sectors. With this strategic investment, BioProcess360 becomes an active shareholder in VERDOT alongside Qualium Investissement, […]
Series B investment underscores high growth opportunity for AI in life sciences BOSTON — Labviva, the leading AI procurement platform for life sciences, today announced the close of its $25 million Series B, bringing its total funding to $55 million. Led by 53 Stations, with continued participation from Biospring Partners, B Capital Group, and Glasswing Ventures, the investment reflects the […]
Proceeds from the financing will be used to broaden and improve the company’s offerings and for operational expansion across facilities, quality, and commercial. CAMARILLO, CA — PBS Biotech (“PBS”), a provider of innovative single-use bioreactor systems and bioprocess development services, has secured $17 million in follow-on growth capital from Avego Management, LLC (“Avego”) and BroadOak […]
Rapid platform adoption with over 50 biopharma and academic partners to date, including 7 of the top 10 pharmaceutical companies Oversubscribed $7M financing proceeds, coupled with revenue, to drive continued growth and launch of next generation products Anil Narasimha, Ph.D. joins as Chief Commercial Officer CAMBRIDGE, Mass.–Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform […]
bit.bio Raises $30 Million Led by M&G Investments to Focus on Tools for the Research, Drug Discovery and Cell Therapy Markets. Jonathan Milner Appointed Interim CEO; Mark Kotter Assumes Vice Chairman Role as Company Expands Board with Distinguished Biotech Leaders. Cambridge, UK – bit.bio, the global leader in cell programming technology, today announced the successful […]
Series B Funding from Major Investors Deerfield Management, Foresite Capital and Medical Excellence Capital among others San Diego – Pleno, a clinical and multi-omics diagnostics company that is revolutionizing biological target detection, today announced the appointment of Dr. Vik Vaz M.D. as its new chief executive officer and to serve on its Board of Directors, […]
OAKLAND, Calif. — Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science using AI, today announced a $22.5 million Series A funding round led by Coatue, with participation from TCV, Index Ventures, F-Prime, and Homebrew. As part of the announcement, the company also introduced Albert Breakthrough™, the first-ever AI solution built specifically […]
The company expects to place Microscoop Mint instruments in the U.S., Europe, and Asia by the end of the year as it builds its commercial infrastructure to support customers worldwide TAIPEI, Taiwan & WATERTOWN, Mass. – Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, today announced the close of a $15 […]
Pay Invoice
Latest Blogs
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.